A Long Non-Coding RNA GATA6-AS1 Inhibits Gastric Intestinal Metaplasia Through the Wnt/β-Catenin Pathway

Xiao,Xiaoqiang Wan,XiaoFang Yang,Jin Tong,Li Zhou,Lei Deng,Wen Li,Jie Luo,Zhilin Luo,Jia Chen,Ling Lin,Jinjun Guo,Zhechuan Mei
DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.20233705.264
2023-01-01
Journal of biological regulators and homeostatic agents
Abstract:Objective: The Correa cascade explains the histopathological process of gastric carcinogenesis, including chronic non-atrophic gastritis (CNAG), chronic atrophic gastritis (CAG), intestinal metaplasia (IM), dysplasia and gastric cancer (GC). IM is consid-ered as a precancerous lesion of gastric cancer. Therefore, we aimed to identify stratification markers from IM that could predict GC occurrence and explore the mechanism of precancerous lesions.Methods: Whole-transcriptome sequencing (RNA-seq) was performed on 18 clinical gastric mucosal specimens from CNAG, CAG, IM, and GC. Based on weighted gene co-expression network analysis (WGCNA), key modules negatively related to the malignant transformation process were identified and hub genes were found. Expression of candidate lncRNAs (long non-coding RNAs) in human gastric tissues was detected by qRT-PCR (quantitative real-time polymerase chain reaction). Human gastric cell lines GES-1 were treated with chenodeoxycholic acid (CDCA). The GATA6-AS1 (GATA6 antisense RNA 1) overexpression vector and antisense oligonucleotides (ASO) were transfected into gastric cell lines and gastric cancer cell lines, respectively, and qRT-PCR and Western blotting evaluated their effects on the expression of IM markers and the Wnt/& beta;-catenin pathway markers. Results: We constructed a hub gene and lncRNAs co-expression network and identified three candidate lncRNAs with the highest connectivity. The expression of GATA6-AS1 was markedly reduced in the IM group and further decreased in the GC group compared with the CNAG group. According to studies in vitro, GATA6-AS1 exhibited negative regulation of intestinal-specific transcription factor CDX2 (Caudal Type Homeobox 2) and its downstream IM marker KLF4 (kruppel-like factor 4) and MUC2 (mouse polyclonal mucin 2), as well as Wnt signaling pathway markers in GES-1 (The human normal gastric epithelial cell line) and SGC7901 cell lines. Furthermore, the overexpressed GATA6-AS1 could reverse CDCA-induced high expression of IM markers and inhibit Wnt signaling pathway marker.Conclusions: GATA6-AS1 possibly serves as the potential marker for IM and could reduce the expression of intestinal metaplasia markers by inhibiting the Wnt signaling pathway, thereby inhibiting the occurrence of IM and intestinal-type gastric cancer.
What problem does this paper attempt to address?